• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布拉氏酵母菌抑制艰难梭菌毒素A与大鼠回肠的结合及肠毒性。

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

作者信息

Pothoulakis C, Kelly C P, Joshi M A, Gao N, O'Keane C J, Castagliuolo I, Lamont J T

机构信息

Evans Memorial Department of Clinical Research, University Hospital, Boston University School of Medicine, Massachusetts.

出版信息

Gastroenterology. 1993 Apr;104(4):1108-15. doi: 10.1016/0016-5085(93)90280-p.

DOI:10.1016/0016-5085(93)90280-p
PMID:8462799
Abstract

BACKGROUND

Saccharomyces boulardii is a nonpathogenic yeast used for the prevention and treatment of Clostridium difficile-associated diarrhea and colitis. However, the mechanism by which S. boulardii exerts its protective effects remains unclear.

METHODS

The binding of [3H]toxin A to its brush border receptor preincubated with S. boulardii-cultured suspension or filtered conditioned medium was measured in vitro. The effect of toxin A on secretion, epithelial permeability, and morphology in rat ileal loops in vivo was also examined in rats pretreated with S. boulardii.

RESULTS

S. boulardii reduced [3H]toxin A-receptor binding in a dose-dependent fashion. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of ileal brush border exposed to S. boulardii-conditioned medium revealed a diminution of all brush border proteins. Treatment of rats with S. boulardii suspension reduced fluid secretion and mannitol permeability caused by toxin A.

CONCLUSIONS

S. boulardii may reduce some of the enterotoxic effects of toxin A by inhibiting toxin A-receptor binding. This effect appears to be manifested by a secreted product of the yeast, possibly a protease.

摘要

背景

布拉氏酵母菌是一种非致病性酵母,用于预防和治疗艰难梭菌相关性腹泻和结肠炎。然而,布拉氏酵母菌发挥其保护作用的机制仍不清楚。

方法

在体外测量[3H]毒素A与预先用布拉氏酵母菌培养悬液或过滤后的条件培养基孵育的刷状缘受体的结合。在用布拉氏酵母菌预处理的大鼠中,还检测了毒素A对体内大鼠回肠襻分泌、上皮通透性和形态的影响。

结果

布拉氏酵母菌以剂量依赖的方式降低了[3H]毒素A-受体的结合。暴露于布拉氏酵母菌条件培养基的回肠刷状缘的十二烷基硫酸钠聚丙烯酰胺凝胶电泳显示所有刷状缘蛋白减少。用布拉氏酵母菌悬液处理大鼠可减少毒素A引起的液体分泌和甘露醇通透性。

结论

布拉氏酵母菌可能通过抑制毒素A-受体结合来降低毒素A的一些肠毒素作用。这种作用似乎由酵母的一种分泌产物(可能是一种蛋白酶)表现出来。

相似文献

1
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.布拉氏酵母菌抑制艰难梭菌毒素A与大鼠回肠的结合及肠毒性。
Gastroenterology. 1993 Apr;104(4):1108-15. doi: 10.1016/0016-5085(93)90280-p.
2
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A和B对人结肠黏膜的作用。
Infect Immun. 1999 Jan;67(1):302-7. doi: 10.1128/IAI.67.1.302-307.1999.
3
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.布拉氏酵母菌蛋白酶可抑制艰难梭菌毒素A对大鼠回肠的作用。
Infect Immun. 1996 Dec;64(12):5225-32. doi: 10.1128/iai.64.12.5225-5232.1996.
4
Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.新生兔回肠中艰难梭菌毒素A敏感性降低与毒素A受体减少有关。
J Clin Invest. 1992 Sep;90(3):822-9. doi: 10.1172/JCI115957.
5
A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum.一种受体诱饵可抑制艰难梭菌毒素A对大鼠回肠的肠毒性作用。
Gastroenterology. 1996 Aug;111(2):433-8. doi: 10.1053/gast.1996.v111.pm8690209.
6
[Response of the IRD intestinal epithelial cell line to Clostridium difficile toxins A and B in rats. Effect of Saccharomyces boulardii].[IRD肠上皮细胞系对大鼠艰难梭菌毒素A和B的反应。布拉酵母菌的作用]
Gastroenterol Clin Biol. 1991;15(1):22-7.
7
Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.兔艰难梭菌毒素A肠炎中的中性粒细胞募集
J Clin Invest. 1994 Mar;93(3):1257-65. doi: 10.1172/JCI117080.
8
Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.艰难梭菌毒素A兔回肠受体的特性。受体偶联G蛋白的证据。
J Clin Invest. 1991 Jul;88(1):119-25. doi: 10.1172/JCI115267.
9
CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.CP-96,345,一种P物质拮抗剂,可抑制大鼠肠道对艰难梭菌毒素A的反应,但对霍乱毒素无此作用。
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):947-51. doi: 10.1073/pnas.91.3.947.
10
Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum.酮替芬可抑制艰难梭菌毒素A诱导的大鼠回肠炎。
Gastroenterology. 1993 Sep;105(3):701-7. doi: 10.1016/0016-5085(93)90886-h.

引用本文的文献

1
Bacterial-Fungal Interactions: Mutualism, Antagonism, and Competition.细菌与真菌的相互作用:共生、拮抗与竞争
Life (Basel). 2025 Aug 5;15(8):1242. doi: 10.3390/life15081242.
2
Enhancing probiotic impact: engineering for optimal acetic acid production and gastric passage tolerance.增强益生菌效果:通过工程设计实现最佳乙酸生成和胃耐受度。
Appl Environ Microbiol. 2024 Jun 18;90(6):e0032524. doi: 10.1128/aem.00325-24. Epub 2024 May 16.
3
Regulation of Gut Microbiota by Herbal Medicines.草药对肠道微生物群的调节。
Curr Drug Metab. 2024;25(2):110-127. doi: 10.2174/0113892002287336240328083220.
4
Neglected gut microbiome: interactions of the non-bacterial gut microbiota with enteric pathogens.被忽视的肠道微生物组:非细菌肠道微生物组与肠道病原体的相互作用。
Gut Microbes. 2023 Jan-Dec;15(1):2226916. doi: 10.1080/19490976.2023.2226916.
5
The Role of Probiotics in Improving Food Safety: Inactivation of Pathogens and Biological Toxins.益生菌在改善食品安全中的作用:病原体和生物毒素的失活。
Curr Pharm Biotechnol. 2024;25(8):962-980. doi: 10.2174/1389201024666230601141627.
6
Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.广谱抗生素对益生菌酵母布拉氏酵母菌在小鼠胃肠道定植的影响。
Sci Rep. 2022 May 25;12(1):8862. doi: 10.1038/s41598-022-12806-0.
7
Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.布拉氏酵母的独特益生菌特性和生物活性代谢产物。
Probiotics Antimicrob Proteins. 2023 Aug;15(4):967-982. doi: 10.1007/s12602-022-09953-1. Epub 2022 May 24.
8
Probiotics: insights and new opportunities for intervention.益生菌:干预的新视角和新机遇。
Crit Rev Microbiol. 2023 May;49(3):414-434. doi: 10.1080/1040841X.2022.2072705. Epub 2022 May 15.
9
The development of live biotherapeutics against infection towards reconstituting gut microbiota.针对重建肠道微生物组的感染,活体生物治疗的发展。
Gut Microbes. 2022 Jan-Dec;14(1):2052698. doi: 10.1080/19490976.2022.2052698.
10
Using a ligate intestinal loop mouse model to investigate Clostridioides difficile adherence to the intestinal mucosa in aged mice.采用结扎肠袢小鼠模型研究艰难梭菌在老年小鼠肠道黏膜的黏附作用。
PLoS One. 2021 Dec 22;16(12):e0261081. doi: 10.1371/journal.pone.0261081. eCollection 2021.